Larvol Delta - ACELYRIN-INC-Announces-Positive-Results-from-Global-Phase-3-Clinical-Trial-of-Izokibep-in-Hidradenitis-Suppurativa-to-be-Highlighted-in-LateBreaking-Oral-Presentation-at-EADV-2024

izokibep (ABY-035) - ACELYRIN

https://www.globenewswire.com/news-release/2024/09/19/2948861/0/en/ACELYRIN-INC-Announces-Positive-Results-from-Global-Phase-3-Clinical-Trial-of-Izokibep-in-Hidradenitis-Suppurativa-to-be-Highlighted-in-Late-Breaking-Oral-Presentation-at-EADV-2024.html

Sep 19, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next